Otsuka America Pharmaceutical, Inc. drugs

8 results

  • abilify

    (ARIPIPRAZOLE)
    Otsuka America Pharmaceutical, Inc.
    ABILIFY (aripiprazole) is indicated for the treatment of schizophrenia, acute manic and mixed episodes associated with Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and treatment of Tourette's disorder.
    Medication Details
    Drug Interactions

  • abilify mycite

    (ARIPIPRAZOLE)
    Otsuka America Pharmaceutical, Inc.
    ABILIFY MYCITE is indicated for treating adults with schizophrenia, bipolar I disorder (including both acute and maintenance phases), and as adjunctive therapy for Major Depressive Disorder. It features an Ingestible Event Marker (IEM) sensor to track medication ingestion.
    Medication Details
    Drug Interactions

  • busulfex

    (busulfan)
    Otsuka America Pharmaceutical, Inc.
    BUSULFEX is indicated for use alongside cyclophosphamide as a conditioning regimen before allogeneic hematopoietic progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Medication Details
    Drug Interactions

  • jynarque

    (tolvaptan)
    Otsuka America Pharmaceutical, Inc.
    JYNARQUE is indicated to slow the decline of kidney function in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).
    Medication Details
    Drug Interactions

  • rexulti

    (brexpiprazole)
    Otsuka America Pharmaceutical, Inc.
    REXULTI is indicated as an adjunctive treatment for major depressive disorder in adults, for the treatment of schizophrenia in adults and patients aged 13 and older, and for agitation associated with Alzheimer's disease. It is not intended for as-needed treatment of agitation.
    Medication Details
    Drug Interactions

  • samsca

    (tolvaptan)
    Otsuka America Pharmaceutical, Inc.
    SAMSCA® is indicated for treating clinically significant hypervolemic and euvolemic hyponatremia in patients, including those with heart failure and SIADH. It is not recommended for urgent serum sodium increases to prevent neurological symptoms, and its symptomatic benefits have not been established.
    Medication Details
    Drug Interactions